Cyclosporine: Difference between revisions
(peds dosing) |
(special populations edits) |
||
| Line 26: | Line 26: | ||
==Special Populations== | ==Special Populations== | ||
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: | *[[Drug Ratings in Pregnancy|Pregnancy Rating]]: Pregnancy Category C | ||
*[[Lactation risk categories|Lactation risk]]: | *[[Lactation risk categories|Lactation risk]]: safety unknown | ||
===Renal Dosing=== | ===Renal Dosing=== | ||
*Adult: | *Adult: | ||
**transplant: no adjustment | |||
**rheumatoid arthritis or psoriasis: contraindicated in renal impairment | |||
*Pediatric: | *Pediatric: | ||
** transplant: no adjustment | |||
===Hepatic Dosing=== | ===Hepatic Dosing=== | ||
*Adult: | *Adult: not defined, caution advised | ||
*Pediatric: | *Pediatric: not defined, caution advised | ||
==Contraindications== | ==Contraindications== | ||
Revision as of 01:43, 9 February 2016
Administration
- Type: immunosuppressant
- Dosage Forms: 25,100; 100/mL
- Routes of Administration: PO, injection
- Common Trade Names: Sandimmune
Adult Dosing
Organ transplant rejection prophylaxis
- Dosing protocols vary
- Start: 7-9 mg/kg/day PO divided BID; give 1st dose 4-12 hr pre-transplant or postop
- For heart, kidney, or liver transplant, adjust dose based on target levels, rejection status, adverse effects
Rheumatoid arthritis, severe
- Start: 2.5 mg/kg/day PO divided BID, increase 0.5-0.75 mg/kg/day after 8 wk and after 12 wk; Max: 4 mg/kg/day
- Use alone or with methotrexate; decreased 25-50% PRN adverse effects, discontinue if no benefit by 16 wks
Psoriasis, severe recalcitrant plaque
- Start: 2.5 mg/kg/day PO divided BID, increase 0.5 mg/kg/day q 2 wk after 4 wk; Max: 4 mg/kg/day
- Decrease 25-50% PRN adverse effects, discontinue if inadequate response after 6 weeks on max tolerated dose
Pediatric Dosing
Organ transplant rejection prophylaxis
- Dosing protocols vary
- Start 7-9 mg/kg/day PO divided BID, give 1st dose 4-12 hr pre-transplant or post op
- For heart, kidney, or liver transplant, adjust dose based on target levels, rejection status, adverse effects
Special Populations
- Pregnancy Rating: Pregnancy Category C
- Lactation risk: safety unknown
Renal Dosing
- Adult:
- transplant: no adjustment
- rheumatoid arthritis or psoriasis: contraindicated in renal impairment
- Pediatric:
- transplant: no adjustment
Hepatic Dosing
- Adult: not defined, caution advised
- Pediatric: not defined, caution advised
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
